 |
Scott Spangler, Principal Data Scientist, IBM Watson Innovations, demonstrates how IBM Watson cognitive technology can now visually display connections in scientific literature and drug information.
In this image, Watson displays protein pathways that can help researchers accelerate scientific breakthroughs by spotting linkages that were previously undetected.
Courtesy of IBM / Jon Simon / Feature Photo Service for IBM |
|
New York, N.Y., USA - August 28, 2014
• Next Milestone in Cognitive Computing is Accelerating Scientific and Industrial Research
• Baylor College of Medicine Speeds Understanding of the Biology of Diseases
• Johnson & Johnson, Sanofi and New York Genome Center Launch Life Science Research Projects
IBM (NYSE: IBM)
today announced significant advances in Watson's cognitive computing capabilities that are enabling researchers to accelerate the pace of scientific breakthroughs by discovering previously unknown connections in Big Data.
Available now as a cloud service, IBM's Watson Discovery Advisor is designed to scale and accelerate discoveries by research teams.
 |
Scott Spangler, a data scientist with IBM, demonstrates how IBM's Watson cognitive technology can visually display connections in scientific data.
Courtesy of IBM / Jon Simon / Feature Photo Service for IBM |
|
It reduces the time needed to test hypotheses and formulate conclusions that can advance their work - from months to days and days to just hours - bringing new levels of speed and precision to research and development.
Building on Watson's ability to understand nuances in natural language, Watson Discovery Advisor can understand the language of science, such as how chemical compounds interact, making it a uniquely powerful tool for researchers in life sciences and other industries.
 |
Infographic: IBM Watson Transforms R&D Discoveries with Data.
Courtesy of IBM |
|
Researchers and scientists from leading academic, pharmaceutical and other commercial research centers have begun deploying IBM's new Watson Discovery Advisor to rapidly analyze and test hypotheses using data in millions of scientific papers available in public databases.
 |
Courtesy of IBM |
|
A new scientific research paper is published nearly every 30 seconds, which equals more than a million annually (Source: CiteSeerx).
According to the
National Institutes of Health, a typical researcher reads about
23 scientific papers per month, which
translates to nearly 300 per year, making it humanly impossible to keep up with the ever-growing body of scientific material available.
 |
Courtesy of IBM |
|
In 2013, the top
1,000 research and development companies spent more than
$600 billion annually on research alone (Source: Strategy&).
Progress can be slow, taking an average of 10 to 15 years for a promising pharmaceutical treatment to progress from the initial research stage into practice (Source: Pharmaceutical Research and Manufacturers of America).
 |
Courtesy of IBM |
|
Using Watson Discovery Advisor, researchers can uncover new relationships and recognize unexpected patterns among data that have the potential to significantly improve and accelerate the discovery process in research and science.
 |
Courtesy of IBM |
|
“We're entering an extraordinary age of data-driven discovery," said
Mike Rhodin, senior vice president, IBM Watson Group.
"Today's announcement is a natural extension of Watson's cognitive computing capability. We're empowering researchers with a powerful tool which will help increase the impact of investments organizations make in R&D, leading to significant breakthroughs."
 |
Courtesy of IBM |
|
Leading life sciences organizations are deploying Watson Discovery Advisor to advance discoveries in ongoing research projects, including Baylor College of Medicine, Johnson & Johnson and The New York Genome Center.
 |
Courtesy of IBM |
|
In a retrospective, peer reviewed study released this week by
Baylor College of Medicine and
IBM, scientists demonstrated a possible new path for generating scientific questions that may be helpful in the long term development of new, effective treatments for disease.
In a matter of weeks, biologists and data scientists using the
Baylor Knowledge Integration Toolkit (KnIT), based on Watson technology, accurately identified proteins that modify
p53, an important protein related to many cancers, which can eventually lead to better efficacy of drugs and other treatments.
A feat that would have taken researchers years to accomplish without
Watson's cognitive capabilities, Watson analyzed 70,000 scientific articles on p53 to predict proteins that turn on or off p53's activity.
This automated analysis led the
Baylor cancer researchers to identify six potential proteins to target for new research.
These results are notable, considering that over the last 30 years, scientists averaged one similar target protein discovery per year.
 |
Courtesy of IBM |
|
“On average, a scientist might read between one and five research papers on a good day,” said
Dr. Olivier Lichtarge, the principal investigator and professor of molecular and human genetics, biochemistry and molecular biology at Baylor College of Medicine.
“To put this in perspective with p53, there are over 70,000 papers published on this protein. Even if I’m reading five papers a day, it could take me nearly 38 years to completely understand all of the research already available today on this protein. Watson has demonstrated the potential to accelerate the rate and the quality of breakthrough discoveries."
 |
Courtesy of IBM |
|
Johnson & Johnson is collaborating with the
IBM Watson Discovery Advisor team to teach
Watson to read and understand scientific papers that detail clinical trial outcomes used to develop and evaluate medications and other treatments.
This collaboration hopes to accelerate comparative effectiveness studies of drugs, which help doctors match a drug with the right set of patients to maximize effectiveness and minimize side effects.
Typically, comparative effectiveness studies are done manually, requiring three people to spend an average of 10 months (2.5 man-years) just to collect the data and prepare them for use before they are able to start analyzing, generating and validating a hypothesis.
In this research study, the team hopes to teach Watson to quickly synthesize the information directly from the medical literature, allowing researchers to start asking questions about the data immediately to determine the effectiveness of a treatment compared to other medications, as well as its side effects.
 |
Courtesy of IBM |
|
Sanofi is exploring how working with
Watson can speed up the discovery of alternate indications for existing drugs (drug re-purposing).
Watson is able to understand and extract key information by reading millions of pages of scientific literature and then visualizes relationships between drugs and other potential diseases they could target while providing supporting evidence each step of the way.
Drug Safety and Toxicity is a major driver of the high failure rate in clinical development / trials.
Sanofi is exploring how
Watson's ability to understand, extract and organize toxicological information can enable researchers to make better informed decisions with respect to candidate progression.
IBM Watson will be supporting the analysis in New York Genome Center’s clinical study to advance genomic medicine.
 |
Courtesy of IBM |
|
The clinical study will initially focus on clinical application of genomics to help oncologists deliver
DNA-based treatment for glioblastoma, an aggressive form of brain cancer that kills more than
13,000 Americans each year.
Despite tremendous discoveries into the genetic drivers of diseases like cancer over the past decade, big data makes it difficult to translate
DNA data into life-saving treatments.
Based on results from the clinical study,
IBM Watson could soon help scale up the availability of personalized treatment options.
Industry Implications
Discovering something new is applicable to many domains such as medicine, law, finance, etc., that all require deep insight into a large body of information and protocols.
Cognitive computing will allow human experts to interact with large bodies of data and research and the knowledge and insight of many other experts in their field.
 |
Courtesy of IBM |
|
For example, Watson could be used to:
• Accelerate a medical researcher's ability to develop life-saving treatments for diseases by synthesizing evidence and removing reliance on serendipity
• Enhance a financial analyst's ability to provide proactive advice to clients
• Improve a lawyer's merger and acquisition strategy with faster, more comprehensive due diligence and document analysis
• Accelerate a government analyst's insight into security, intelligence, border protection and law enforcement and guidance, etc.
• Create new food recipes. Chefs can use Watson to augment their creativity and expertise and help them discover recipes, learning about the language of cooking and food by reading recipes, statistical, molecular and food pairing theories, hedonic chemistry, as well as regional and cultural knowledge
 |
Courtesy of IBM |
|
IBM Watson Discovery Advisor has the potential to
transform industries and professions that rely heavily on data, including law, pharmaceuticals, biotech, education, chemicals, metals, scientific research, engineering, and criminal investigations.
For more information, visit
https://ibm.biz/watsondiscoveryadvisor
IBM Power Systems serves as the infrastructure base of Watson, supporting the high volume of data needed to drive cognitive insights.
Photos are available via the
Associated Press Photo Network and on the Internet at Feature Photo Service's link through
http://www.newscom.com
IBM Watson: Pioneering a New Era of Computing
Three years after its victory on the
TV quiz show Jeopardy!, IBM Watson has evolved to represent a new era of computing, earning recognition from
Frost & Sullivan, which presented
IBM Watson with the 2013 North America Award for New Product Innovation, and Gartner Inc., which cites
IBM Watson in its
Top 10 Strategic Technology Trends for 2014 and predicts that by 2017, 10 percent of computers will be able to learn as
Watson does.
 |
Courtesy of IBM |
|
Today,
Watson is no longer just the world's most famous game-playing computer.
IBM has put Watson to work in various industries.
In healthcare, IBM is co-developing an application with Memorial Sloan-Kettering Cancer Center, and partnering with WellPoint, the University of Texas MD Anderson Cancer Center, and the Cleveland Clinic Lerner College of Medicine.
 |
Courtesy of IBM |
|
Additionally,
IBM has partnered with numerous colleges and universities across the country to teach Watson capabilities and cognitive computing technology to the next generation workforce.
For more information on
IBM Watson, please visit:
www.ibmwatson.com
To join the social discussion about
Watson, include the hashtag
#ibmwatson.
Follow
Watson on Facebook and see
Watson on YouTube and
Flickr.
For more insights on this story please read these posts on
IBM's A Smarter Planet blog: ibm.co/1tFVdly, ibm.co/XPzxIY, ibm.co/1vj8dQZ
 |
Courtesy of IBM |
|
Contacts information
John Connolly
IBM Media Relations
781-636-8512
jconnol@us.ibm.com
Tod Freeman
IBM Media Relations
415.320.5893
tefreema@us.ibm.com
 |
Courtesy of IBM |
|
Video
Introducing IBM Watson Discovery Advisor
http://www.youtube.com/watch?v=qry_zGZFjOc
Source: IBM
http://www-03.ibm.com/press/us/en/index.wss
 |
Courtesy of IBM |
|
ASTROMAN Magazine - 2014.08.10
Wroclaw University of Technology Delivers Personalized Classrooms on IBM Cloud Infrastructure
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1772
ASTROMAN Magazine - 2014.08.02
IBM acquires CrossIdeas to Expand Security Offerings with Identity Intelligence
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1767
ASTROMAN Magazine - 2014.07.16
Apple and IBM Forge Global Partnership to Transform Enterprise Mobility
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1757
ASTROMAN Magazine - 2014.07.12
IBM Announces $3 Billion Research Initiative to Tackle Chip Grand Challenges for Cloud and Big Data Systems
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1755
ASTROMAN Magazine - 2014.07.08
City of Madrid Implements IBM's Large Smarter Cities Environmental Analytics Project
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1751
ASTROMAN Magazine - 2014.06.27
Qatar Public Works Authority 'Ashghal' Selects IBM for Smarter Infrastructure
https://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1741
ASTROMAN Magazine - 2014.05.11
Report: IBM Named #1 Preferred Provider of IaaS Cloud by Enterprises
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1710
ASTROMAN Magazine – 2014.02.01
IBM and Twitter Announce Patent and Cross-License Agreement. Twitter purchases 900 patents from IBM
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1648
ASTROMAN Magazine - 2013.12.22
IBM to Acquire Aspera to Help Companies Speed Global Movement of Big Data
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1610
ASTROMAN Magazine - 2013.11.16
IBM Watson's Next Venture: Fueling New Era of Cognitive Apps Built in the Cloud by Developers
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1587
ASTROMAN Magazine - 2013.10.26
President Barack Obama to Visit IBM'S P-TECH School in Brooklyn, NY, USA
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1576
ASTROMAN Magazine - 2013.09.21
IBM Acquires Daeja Image Systems Ltd.
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1557
ASTROMAN Magazine - 2013.09.01
IBM Closes Acquisition of CSL International
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1541
ASTROMAN Magazine – 2013.08.17
IBM to Acquire Trusteer to Help Companies Combat Financial Fraud and Advanced Security Threats
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1519
ASTROMAN Magazine – 2013.08.17
IBM Awarded 10 Year US$1 Billion Cloud Hosting Services Contract
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1518
ASTROMAN Magazine – 2013.04.08
IBM To Open Cloud Lab For Wall Street Clients
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1440
ASTROMAN Magazine – 2012.03.03
IBM Forms Watson Healthcare Advisory Board
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1191
ASTROMAN Magazine – 2011.11.01
IBM Watson Heads to Harvard, MIT to Explore Future of Technology in Business
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1092
ASTROMAN Magazine – 2011.09.12
WellPoint and IBM Announce Agreement to Put Watson to Work in Health Care
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1056
ASTROMAN Magazine – 2011.06.17
IBM's Watson Computing System Honored as "Person of the Year"
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=998
ASTROMAN Magazine – 2011.02.20
IBM to Collaborate with Nuance to Apply IBM's "Watson" Analytics Technology to Healthcare
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=899
ASTROMAN Magazine – 2011.02.20
IBM "Watson" to Challenge Humans at Jeopardy!
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=898
ASTROMAN Magazine – 2010.12.25
IBM's "Watson" Computing System to Challenge All Time Greatest Jeopardy! Champions
http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=864
Editor-in-Chief of ASTROMAN magazine: Roman Wojtala, PhD.